1. Home
  2. GAME vs BOLD Comparison

GAME vs BOLD Comparison

Compare GAME & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GAME
  • BOLD
  • Stock Information
  • Founded
  • GAME 2011
  • BOLD 2018
  • Country
  • GAME United States
  • BOLD United States
  • Employees
  • GAME N/A
  • BOLD N/A
  • Industry
  • GAME
  • BOLD
  • Sector
  • GAME
  • BOLD
  • Exchange
  • GAME Nasdaq
  • BOLD Nasdaq
  • Market Cap
  • GAME 74.8M
  • BOLD 24.4M
  • IPO Year
  • GAME 2009
  • BOLD 2024
  • Fundamental
  • Price
  • GAME $0.95
  • BOLD $1.19
  • Analyst Decision
  • GAME Strong Buy
  • BOLD Buy
  • Analyst Count
  • GAME 3
  • BOLD 3
  • Target Price
  • GAME $3.67
  • BOLD $4.00
  • AVG Volume (30 Days)
  • GAME 25.6M
  • BOLD 105.1K
  • Earning Date
  • GAME 08-13-2025
  • BOLD 08-11-2025
  • Dividend Yield
  • GAME N/A
  • BOLD N/A
  • EPS Growth
  • GAME N/A
  • BOLD N/A
  • EPS
  • GAME N/A
  • BOLD N/A
  • Revenue
  • GAME $99,579,536.00
  • BOLD N/A
  • Revenue This Year
  • GAME $6.08
  • BOLD N/A
  • Revenue Next Year
  • GAME $21.94
  • BOLD N/A
  • P/E Ratio
  • GAME N/A
  • BOLD N/A
  • Revenue Growth
  • GAME 77.06
  • BOLD N/A
  • 52 Week Low
  • GAME $0.50
  • BOLD $1.00
  • 52 Week High
  • GAME $2.87
  • BOLD $4.72
  • Technical
  • Relative Strength Index (RSI)
  • GAME 42.59
  • BOLD N/A
  • Support Level
  • GAME $1.47
  • BOLD N/A
  • Resistance Level
  • GAME $1.24
  • BOLD N/A
  • Average True Range (ATR)
  • GAME 0.26
  • BOLD 0.00
  • MACD
  • GAME -0.10
  • BOLD 0.00
  • Stochastic Oscillator
  • GAME 0.02
  • BOLD 0.00

About GAME GameSquare Holdings Inc.

GameSquare Holdings Inc is engaged in revolutionizing the way brands and game publishers connect with hard-to-reach Gen Z, Gen Alpha, and Millennial audiences. It's next generation media, entertainment, and technology helps creators and maximize their brand partners' return on investment. Its purpose-built platform provides marketing and creative services, offers data and analytics solutions, and amplifies awareness through FaZe Clan.

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

Share on Social Networks: